BIOMAT Database Logo BIOMAT Database Logo

[Chromosomal alterations in chronic myeloid leukemia]. 1962

L BOSI, and G L CASTOLDI, and E PUNTURIERI, and N RICCI

UI MeSH Term Description Entries
D007938 Leukemia A progressive, malignant disease of the blood-forming organs, characterized by distorted proliferation and development of leukocytes and their precursors in the blood and bone marrow. Leukemias were originally termed acute or chronic based on life expectancy but now are classified according to cellular maturity. Acute leukemias consist of predominately immature cells; chronic leukemias are composed of more mature cells. (From The Merck Manual, 2006) Leucocythaemia,Leucocythemia,Leucocythaemias,Leucocythemias,Leukemias
D007951 Leukemia, Myeloid Form of leukemia characterized by an uncontrolled proliferation of the myeloid lineage and their precursors (MYELOID PROGENITOR CELLS) in the bone marrow and other sites. Granulocytic Leukemia,Leukemia, Granulocytic,Leukemia, Myelocytic,Leukemia, Myelogenous,Myelocytic Leukemia,Myelogenous Leukemia,Myeloid Leukemia,Leukemia, Monocytic, Chronic,Monocytic Leukemia, Chronic,Chronic Monocytic Leukemia,Chronic Monocytic Leukemias,Granulocytic Leukemias,Leukemia, Chronic Monocytic,Leukemias, Chronic Monocytic,Leukemias, Granulocytic,Leukemias, Myelocytic,Leukemias, Myelogenous,Leukemias, Myeloid,Monocytic Leukemias, Chronic,Myelocytic Leukemias,Myelogenous Leukemias,Myeloid Leukemias
D002875 Chromosomes In a prokaryotic cell or in the nucleus of a eukaryotic cell, a structure consisting of or containing DNA which carries the genetic information essential to the cell. (From Singleton & Sainsbury, Dictionary of Microbiology and Molecular Biology, 2d ed) Chromosome
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D015464 Leukemia, Myelogenous, Chronic, BCR-ABL Positive Clonal hematopoetic disorder caused by an acquired genetic defect in PLURIPOTENT STEM CELLS. It starts in MYELOID CELLS of the bone marrow, invades the blood and then other organs. The condition progresses from a stable, more indolent, chronic phase (LEUKEMIA, MYELOID, CHRONIC PHASE) lasting up to 7 years, to an advanced phase composed of an accelerated phase (LEUKEMIA, MYELOID, ACCELERATED PHASE) and BLAST CRISIS. Granulocytic Leukemia, Chronic,Leukemia, Granulocytic, Chronic,Leukemia, Myelocytic, Chronic,Leukemia, Myelogenous, Chronic,Leukemia, Myeloid, Chronic,Myelocytic Leukemia, Chronic,Myelogenous Leukemia, Chronic,Myeloid Leukemia, Chronic,Leukemia, Chronic Myelogenous,Leukemia, Chronic Myeloid,Leukemia, Myelogenous, Ph1 Positive,Leukemia, Myelogenous, Ph1-Positive,Leukemia, Myeloid, Ph1 Positive,Leukemia, Myeloid, Ph1-Positive,Leukemia, Myeloid, Philadelphia Positive,Leukemia, Myeloid, Philadelphia-Positive,Myelogenous Leukemia, Ph1-Positive,Myeloid Leukemia, Ph1-Positive,Myeloid Leukemia, Philadelphia-Positive,Chronic Granulocytic Leukemia,Chronic Granulocytic Leukemias,Chronic Myelocytic Leukemia,Chronic Myelocytic Leukemias,Chronic Myelogenous Leukemia,Chronic Myelogenous Leukemias,Chronic Myeloid Leukemia,Chronic Myeloid Leukemias,Granulocytic Leukemias, Chronic,Leukemia, Chronic Granulocytic,Leukemia, Chronic Myelocytic,Leukemia, Ph1-Positive Myelogenous,Leukemia, Ph1-Positive Myeloid,Leukemia, Philadelphia-Positive Myeloid,Leukemias, Chronic Granulocytic,Leukemias, Chronic Myelocytic,Leukemias, Chronic Myelogenous,Leukemias, Chronic Myeloid,Leukemias, Ph1-Positive Myelogenous,Leukemias, Ph1-Positive Myeloid,Leukemias, Philadelphia-Positive Myeloid,Myelocytic Leukemias, Chronic,Myelogenous Leukemia, Ph1 Positive,Myelogenous Leukemias, Chronic,Myelogenous Leukemias, Ph1-Positive,Myeloid Leukemia, Ph1 Positive,Myeloid Leukemia, Philadelphia Positive,Myeloid Leukemias, Chronic,Myeloid Leukemias, Ph1-Positive,Myeloid Leukemias, Philadelphia-Positive,Ph1-Positive Myelogenous Leukemia,Ph1-Positive Myelogenous Leukemias,Ph1-Positive Myeloid Leukemia,Ph1-Positive Myeloid Leukemias,Philadelphia-Positive Myeloid Leukemia,Philadelphia-Positive Myeloid Leukemias

Related Publications

L BOSI, and G L CASTOLDI, and E PUNTURIERI, and N RICCI
Chromosomal alteration of erythropoietic cells in chronic myeloid leukemia.
May 1963, Acta haematologica,
L BOSI, and G L CASTOLDI, and E PUNTURIERI, and N RICCI
Additional chromosomal abnormalities in Philadelphia-positive chronic myeloid leukemia.
January 2008, Hematology/oncology and stem cell therapy,
L BOSI, and G L CASTOLDI, and E PUNTURIERI, and N RICCI
Complex chromosomal rearrangements in patients with chronic myeloid leukemia.
July 2006, Cancer genetics and cytogenetics,
L BOSI, and G L CASTOLDI, and E PUNTURIERI, and N RICCI
Additional chromosomal abnormalities in Philadelphia positive chronic myeloid leukemia.
January 2020, Pakistan journal of medical sciences,
L BOSI, and G L CASTOLDI, and E PUNTURIERI, and N RICCI
Molecular and chromosomal alterations: new therapies for relapsed acute myeloid leukemia.
February 2008, Hematology (Amsterdam, Netherlands),
L BOSI, and G L CASTOLDI, and E PUNTURIERI, and N RICCI
[Chromosomal observations on myeloid progenitor cells in chronic myelocytic leukemia].
February 1984, Zhonghua nei ke za zhi,
L BOSI, and G L CASTOLDI, and E PUNTURIERI, and N RICCI
Persistent clonal chromosomal abnormalities in a chronic myeloid leukemia patient.
January 2016, Pediatrics international : official journal of the Japan Pediatric Society,
L BOSI, and G L CASTOLDI, and E PUNTURIERI, and N RICCI
Chromosomal Instability in Chronic Myeloid Leukemia: Mechanistic Insights and Effects.
May 2022, Cancers,
L BOSI, and G L CASTOLDI, and E PUNTURIERI, and N RICCI
Chromosomal alterations associated with evolution from myelodysplastic syndrome to acute myeloid leukemia.
October 2000, Leukemia research,
L BOSI, and G L CASTOLDI, and E PUNTURIERI, and N RICCI
Philadelphia-negative chromosomal evolution during treatment for chronic myeloid leukemia.
February 2012, Genetics and molecular research : GMR,
Copied contents to your clipboard!